Prostate vs. colorectal screening
This article was originally published in The Gray Sheet
Executive Summary
75% of U.S. men aged 50 and older have had a prostate-specific antigen (PSA) test to screen for prostate cancer but only 63% have received any colorectal cancer screening test, according to Brenda Sirovich, MD, VA Outcomes Group, White Junction, Vt., et al. Reporting in the March 19 issue of the Journal of the American Medical Association, the authors conclude that men may be "more accepting" of a blood test for PSA than more invasive colorectal cancer tests. Physicians "should ensure that men who choose to be screened for cancer are aware of the known mortality benefit of colorectal cancer screening and the uncertain benefits of screening for prostate cancer"...